Amydis

San Diego, United States

Amydis is a pharmaceutical company that focuses on developing innovative chemistry to detect diseases.

$2.5M raised

Mar 2026

Grant

Biotechnology Health Diagnostics Neuroscience Pharmaceutical

Top Investors

Michael J. Fox Foundation National Institutes of Health National Institute on Aging National Institute of Neurological Disorders and Stroke

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Amydis

How much funding has Amydis raised?

Amydis has raised $2.5M in total funding. The most recent round was Grant. The last funding was announced in March 2026.

Who are Amydis's investors?

Amydis's investors include Michael J. Fox Foundation, National Institutes of Health, National Institute on Aging, National Institute of Neurological Disorders and Stroke.

Where is Amydis headquartered?

Amydis is headquartered in San Diego, United States.

What does Amydis do?

Amydis is a pharmaceutical company that focuses on developing innovative chemistry to detect diseases.

What stage is Amydis at?

Amydis is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 11, 2026.

MLA

"Amydis — Funding & Investors." VCBacked, March 11, 2026, https://www.vcbacked.co/company/amydis. Accessed July 2, 2026.

APA

VCBacked. (2026). Amydis — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/amydis

Wikipedia (cite web)

{{cite web |title=Amydis — Funding & Investors |url=https://www.vcbacked.co/company/amydis |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 11, 2026.

Similar Companies in Biotechnology

View all

Allterum Therapeutics

Houston$1.0M

Renaissance BioScience

Advanced Microbiome Interventions

Amsterdam$300K